Weekly 10 hottest news

 Print 
 Hot read  |  Most clicked news  |  Hot tags  |  Hot search  |  Hot search (news clipping) 


     
1. 《大行》瑞銀首次覆蓋聯邦制藥予「買入」評級 目標價18.9元

2026-02-05T  
2. 國家藥監局:「十五五」期間將大力支持生物製造產業創新發展

2026-02-04T  
3. 中國銀河獲批發行最多200億人幣次級債券

2026-02-04T  
4. 康哲藥業創新藥CMS-D017獲准開展臨床試驗

2026-02-04T  
5. 《大行》中金升康哲藥業目標價至16.5元 維持「跑贏行業」評級

2026-02-03T  
6. 《大行》里昂料石藥BD交易將轉化為經常性收入 升目標價至19元

2026-02-03T  
7. 天津港發展(03382.HK)附屬斥3,187萬人民幣建危化品監管平台

2025-12-21T  
8. 《大行》匯豐研究升石藥收入及盈測 目標價上調至11元

2026-02-05T  
9. *恆指跌幅擴至逾500點 中資電訊股急挫聯通瀉9% 比亞迪跌半成

2026-02-02T  
10. 聯邦制藥UBT251注射液OSA適應症獲臨床試驗默示許可

2026-02-03T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.